CA
CVKD icon

CoreCap Advisors’s Cadrenal Therapeutics CVKD Stock Holding History

CoreCap Advisors’s Portfolio CVKD Stock Details CVKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29K Buy
+1,285
New +$6.1K ﹤0.01% 2319

Other funds holding CVKD

GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CoreCap Advisors's CVKD Position: Q2 2026 in Review

CoreCap Advisors opened a new position in Cadrenal Therapeutics (CVKD) in Q2 2026: 1,285 shares worth $4.29K. The stake represents ﹤0.01% of the portfolio and ranks #2319 among its holdings.

4 funds tracked by Wall St. Rank hold CVKD as of Q2 2026.

  • CoreCap Advisors held 1,285 shares of Cadrenal Therapeutics worth $4.29K as of Q2 2026.
  • Cadrenal Therapeutics was a new CoreCap Advisors position in Q2 2026.
  • Cadrenal Therapeutics made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2319 holding.
  • 4 funds tracked by Wall St. Rank held Cadrenal Therapeutics as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.